Company / Income Tax
Jazz Pharmaceuticals Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$272.4M
FY2025
5-year range
-$272.4M / $33.5M
FY2021-FY2025
Trend
-198.0%
vs FY2024
Sector context
#203 of 204
Health Care
What the data says
Among 204 Health Care companies, Jazz Pharmaceuticals is in the top 0% for income tax. Income Tax has fluctuated over the past 10 years, ranging from -$272M in FY2025 to $135M in FY2018.
Based on SEC 10-K filings.
-$272M in FY2025.
Improved from -$120M to -$272M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 204This company -$272.4M Sector average $118.7M
▼
-329.5% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 198.0% year-over-year.
- Ranks #203 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$272.4M | -198.0% |
| FY2024 | -$91.4M | +23.8% |
| FY2023 | -$119.9M | -457.8% |
| FY2022 | $33.5M | +145.8% |
| FY2021 | -$73.2M | -191.3% |
| FY2020 | $80.2M | +267.9% |
| FY2019 | -$47.7M | -135.3% |
| FY2018 | $135.2M | +383.3% |
| FY2017 | -$47.7M | -150.7% |
| FY2016 | $94.2M | -11.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026